Certain Memoranda and Reports. Without limiting any other provision of this Agreement requiring FLX to provide to Merck documentation related to the Study, FLX shall provide to Merck drafts and final versions of: (a) a memorandum having top-line results from the completed Study (the “Top-Line Results Memo”); and (b) final Study report (“Final Study Report”) for the Study as described below.
Appears in 2 contracts
Sources: Clinical Trial Collaboration and Supply Agreement (RAPT Therapeutics, Inc.), Clinical Trial Collaboration and Supply Agreement (RAPT Therapeutics, Inc.)